Advertisement
UK markets close in 7 hours 51 minutes
  • FTSE 100

    8,078.29
    +37.91 (+0.47%)
     
  • FTSE 250

    19,613.14
    -106.23 (-0.54%)
     
  • AIM

    753.92
    -0.77 (-0.10%)
     
  • GBP/EUR

    1.1659
    +0.0015 (+0.12%)
     
  • GBP/USD

    1.2497
    +0.0034 (+0.27%)
     
  • Bitcoin GBP

    51,355.31
    -2,103.70 (-3.94%)
     
  • CMC Crypto 200

    1,390.67
    +8.10 (+0.59%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.99
    +0.18 (+0.22%)
     
  • GOLD FUTURES

    2,334.30
    -4.10 (-0.18%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,271.01
    +69.74 (+0.41%)
     
  • DAX

    17,980.96
    -107.74 (-0.60%)
     
  • CAC 40

    8,061.14
    -30.72 (-0.38%)
     

Is It Too Late to Buy Invitae Stock?

Is It Too Late to Buy Invitae Stock?

Invitae (NYSE: NVTA) is a promising business specializing in genetic testing, which could be the wave of the future in healthcare. Genetic tests can uncover mutations or variants in your DNA, which can help prevent illnesses and treat them more effectively. Invitae, for instance, has been incurring significant losses and is a bit of a risky company to invest in.